Trials / Completed
CompletedNCT06310616
A Study to Investigate the Potential Drug-Drug Interaction Between VH4524184 and Oral Contraceptive (Loestrin) in Healthy Adult Female Participants
A Phase 1, Single-center, Open-label Study to Evaluate the Pharmacokinetics of Oral Contraceptive Containing Norethindrone and Ethinyl Estradiol (Loestrin) When Co-administered With VH4524184 in Healthy Adult Female Participants
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 26 (actual)
- Sponsor
- ViiV Healthcare · Industry
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
This study aims to assess any impact of VH4524184 on the pharmacokinetic (PK) profile of an ethinyl estradiol (EE) and norethindrone acetate (NEA) containing oral contraceptive (OC) administered to healthy adult female participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | VH4524184 | VH4524184 will be administered. |
| DRUG | Loestrin | Loestrin will be administered. |
Timeline
- Start date
- 2024-03-06
- Primary completion
- 2024-08-15
- Completion
- 2024-08-15
- First posted
- 2024-03-15
- Last updated
- 2024-12-10
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06310616. Inclusion in this directory is not an endorsement.